What is a stock summary page? Click here for an overview.
Business Description
Boule Diagnostics AB
NAICS : 339112
ISIN : SE0011231158
Compare
Compare
Traded in other countries / regions
BOUL.Sweden8BD.GermanyBOULs.UKBDABF.USA IPO Date
2011-06-27Description
Boule Diagnostics AB is a company operating in the diagnostics market. It is engaged in the development, manufacturing and marketing instruments and consumables for blood diagnostics. The firm focuses on the decentralized market segment. The systems are intended for small and medium-sized hospitals, clinics and laboratories within outpatient care. Through its subsidiaries, the Group operates in Sweden, USA, and China.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.12 | |||||
| Equity-to-Asset | 0.46 | |||||
| Debt-to-Equity | 0.72 | |||||
| Debt-to-EBITDA | -0.76 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -0.24 | |||||
| Beneish M-Score | -4.78 | |||||
| WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -5.5 | |||||
| 3-Year FCF Growth Rate | -28.1 | |||||
| 3-Year Book Growth Rate | -13.7 | |||||
| Future 3-5Y Total Revenue Growth Rate Estimate | 4.6 |
Momentum Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 18.06 | |||||
| 9-Day RSI | 24.98 | |||||
| 14-Day RSI | 30.67 | |||||
| 3-1 Month Momentum % | -0.23 | |||||
| 6-1 Month Momentum % | 15.45 | |||||
| 12-1 Month Momentum % | -8.7 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.97 | |||||
| Quick Ratio | 0.75 | |||||
| Cash Ratio | 0.09 | |||||
| Days Inventory | 76.13 | |||||
| Days Sales Outstanding | 96.65 | |||||
| Days Payable | 41.56 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -12.3 | |||||
| Shareholder Yield % | -1.23 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 45.18 | |||||
| Operating Margin % | -40.13 | |||||
| Net Margin % | -39.98 | |||||
| FCF Margin % | -7.05 | |||||
| ROE % | -56 | |||||
| ROA % | -32.05 | |||||
| ROIC % | -29.49 | |||||
| 3-Year ROIIC % | -312.77 | |||||
| ROC (Joel Greenblatt) % | -168.35 | |||||
| ROCE % | -54.33 | |||||
| Years of Profitability over Past 10-Year | 8 |
GF Value Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Forward PE Ratio | 12.67 | |||||
| Shiller PE Ratio | 36.52 | |||||
| PS Ratio | 0.53 | |||||
| PB Ratio | 1.09 | |||||
| Price-to-Tangible-Book | 3.78 | |||||
| Price-to-Operating-Cash-Flow | 6.38 | |||||
| EV-to-EBIT | -1.83 | |||||
| EV-to-Forward-EBIT | 11.13 | |||||
| EV-to-EBITDA | -1.83 | |||||
| EV-to-Forward-EBITDA | 7.69 | |||||
| EV-to-Revenue | 0.84 | |||||
| EV-to-Forward-Revenue | 0.84 | |||||
| EV-to-FCF | -11.87 | |||||
| Price-to-GF-Value | 0.83 | |||||
| Price-to-Median-PS-Value | 0.25 | |||||
| Earnings Yield (Greenblatt) % | -54.64 | |||||
| FCF Yield % | -13.35 | |||||
| Forward Rate of Return (Yacktman) % | 1.86 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Boule Diagnostics AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 558.5 | ||
| EPS (TTM) (kr) | -5.75 | ||
| Beta | 1.12 | ||
| 3-Year Sharpe Ratio | -0.98 | ||
| 3-Year Sortino Ratio | -1.07 | ||
| Volatility % | 29.67 | ||
| 14-Day RSI | 30.67 | ||
| 14-Day ATR (kr) | 0.525632 | ||
| 20-Day SMA (kr) | 8.7971 | ||
| 12-1 Month Momentum % | -8.7 | ||
| 52-Week Range (kr) | 6.5 - 11.5 | ||
| Shares Outstanding (Mil) | 38.83 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Boule Diagnostics AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Boule Diagnostics AB Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Boule Diagnostics AB Frequently Asked Questions
What is Boule Diagnostics AB(OSTO:BOUL)'s stock price today?
The current price of OSTO:BOUL is kr7.60. The 52 week high of OSTO:BOUL is kr11.50 and 52 week low is kr6.50.
When is next earnings date of Boule Diagnostics AB(OSTO:BOUL)?
The next earnings date of Boule Diagnostics AB(OSTO:BOUL) is 2025-04-28.
Does Boule Diagnostics AB(OSTO:BOUL) pay dividends? If so, how much?
Boule Diagnostics AB(OSTO:BOUL) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers